The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Medicinal mushrooms in prevention and control of diabetes mellitus
Abstract
Diabetes mellitus is a life-threatening chronic metabolic disease caused by lack of insulin and/or insulin dysfunction, characterized by high levels of glucose in the blood (hyperglycemia). Millions worldwide suffer from diabetes and its complications. Significantly, it has been recognized that type 2 diabetes is an important preventable disease and can be avoided or delayed by lifestyle intervention. Presently, there are many chemical and biochemical hypoglycemic agents (synthetic drugs), that are used in treating diabetes and are effective in controlling hyperglycemia. However, as they may have harmful side-effects and fail to significantly alter the course of diabetic complications, natural anti-diabetic drugs from medicinal plants have attracted a great deal of attention. Medicinal mushrooms have been valued as a traditional source of natural bioactive compounds over many centuries and have been targeted as potential hypoglycemic and anti-diabetic agents. Bioactive metabolites including polysaccharides, proteins, dietary fibres, and many other biomolecules isolated from medicinal mushrooms and their cultured mycelia have been shown to be successful in diabetes treatment as biological anti-hyperglycemic agents. In this review we discuss the biological nature of diabetes and, in particular, explore some promising mushrooms that have experimental anti-diabetic properties, preventing or reducing the development of diabetes mellitus. The importance of medicinal mushrooms as agents of medical nutrition therapy and how their metabolites can be used as supportive candidates for prevention and control of diabetes is explored. Future prospects for this field of study and the difficulties and constraints that might affect the development of rational drug products from medicinal mushrooms are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901
Health benefits of dietary fiber
Anderson, J. W., Baird, P., Davis Jr, R. H., Ferreri, S., Knudtson, M., Koraym, A., Waters, V., & Williams, C. L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00189.x · Cited by 2,239
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805796 · Cited by 1,939
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824 · cited 2×
“…higher than 10 mmol/ l (180 mg/dl), but symptoms may not start to become noticeable until even higher values such as 15–20 mmol/ l (270–360 mg/dl) and over time leads to serious damage to many of the body’s systems, especially the nerves and cardiovascular system (Capes et al. 2001; Anon 2011).”
BackgroundSelf-Management Education for Adults With Type 2 Diabetes
Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H., & Engelgau, M. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1159 · Cited by 1,750 · cited 1×
“The onset of type 2 diabetes has become most common in middle aged or later life, although it is being more frequently seen in adolescents and young adults due to an increase in child obesity and inactivity (Rosenbloom et al. 1999; Norris et al. 2002; Pozzilli and Guglielmi 2009).”
BackgroundEconomic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Global healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.026 · Cited by 1,145
Emerging epidemic of type 2 diabetes in youth
Rosenbloom, A. L., Joe, J. R., Young, R. S., & Winter, W. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.345 · Cited by 1,019 · cited 1×
“The onset of type 2 diabetes has become most common in middle aged or later life, although it is being more frequently seen in adolescents and young adults due to an increase in child obesity and inactivity (Rosenbloom et al. 1999; Norris et al. 2002; Pozzilli and Guglielmi 2009).”
Background
Cited by
The amazing potential of fungi: 50 ways we can exploit fungi industrially
Hyde, K. D., Xu, J., Rapior, S., Jeewon, R., Lumyong, S., Niego, A. G. T., Abeywickrama, P. D., Aluthmuhandiram, J. V. S., Brahamanage, R. S., Brooks, S., et al. (2019) · Fungal Diversity · doi:10.1007/s13225-019-00430-9 · Cited by 811
Self-citationKumar, K., Mehra, R., Guiné, R. P. F., Lima, M. J., Kumar, N., Kaushik, R., Ahmed, N., Yadav, A. N., & Kumar, H. (2021) · Foods · doi:10.3390/foods10122996 · Cited by 312
Hyde, K. D., Dong, Y., Phookamsak, R., Jeewon, R., Bhat, D. J., Jones, E. B. G., Liu, N.-G., Abeywickrama, P. D., Mapook, A., Wei, D., et al. (2020) · Fungal Diversity · doi:10.1007/s13225-020-00439-5 · Cited by 290
Self-citationBioactive metabolites from macrofungi: ethnopharmacology, biological activities and chemistry
De Silva, D. D., Rapior, S., Sudarman, E., Stadler, M., Xu, J., Aisyah Alias, S., & Hyde, K. D. (2013) · Fungal Diversity · doi:10.1007/s13225-013-0265-2 · Cited by 271
Self-citationJayawardena, R. S., Hyde, K. D., Chen, Y. J., Papp, V., Palla, B., Papp, D., Bhunjun, C. S., Hurdeal, V. G., Senwanna, C., Manawasinghe, I. S., et al. (2020) · Fungal Diversity · doi:10.1007/s13225-020-00460-8 · Cited by 122
Self-citation
Metadata
- Authors
- De Silva, D. D., Rapior, S., Hyde, K. D., & Bahkali, A. H.
- Venue
- Fungal Diversity
- Publisher
- BioAcademic Press
- Published
- 2012-09
- Volume
- 56
- Issue
- 1
- Pages
- 1-29
- ISSN
- 1560-2745 (ISSN-L)
- 1878-9129
- OpenAlex
- W1986839704
- Cited by
- 247
- References
- 24
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medicinal mushrooms in prevention and control of diabetes mellitus. https://app.cochat.ai/papers/10.1007/s13225-012-0187-4
- The paper
- De Silva, D. D., Rapior, S., Hyde, K. D., & Bahkali, A. H. (2012). Medicinal mushrooms in prevention and control of diabetes mellitus. Fungal Diversity. https://doi.org/10.1007/s13225-012-0187-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.